# HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)

Study · id `cardio:ct-nct07379190` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07379190](<https://clinicaltrials.gov/study/NCT07379190>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07379190

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 458 participants.

## Technical summary

Registry record NCT07379190. Randomized; single masking; primary purpose treatment. Start 2026-06-22 (actual); primary completion 2029-02-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 458 participants (planned count; ClinicalTrials.gov record NCT07379190, source copy `cardio:ctgov-nct07379190-2026-06-25`, retrieved 2026-10-26)
- Started: 2026-06-22 (actual) (ClinicalTrials.gov record NCT07379190, source copy `cardio:ctgov-nct07379190-2026-06-25`, retrieved 2026-10-26)
- Primary completion: 2029-02-01 (anticipated) (ClinicalTrials.gov record NCT07379190, source copy `cardio:ctgov-nct07379190-2026-06-25`, retrieved 2026-10-26)
- Completion: 2029-05-01 (anticipated) (ClinicalTrials.gov record NCT07379190, source copy `cardio:ctgov-nct07379190-2026-06-25`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07379190, source copy `cardio:ctgov-nct07379190-2026-06-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07379190-2026-06-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
- Condition: Stroke, Acute
- Condition: Stroke, Ischemic
- Condition: Cerebral Infarction
- Intervention (Drug): Tirofiban
- Intervention (Drug): dual antiplatelet therapy
- Lead sponsor: Weifang Medical University
- Lead sponsor class: OTHER
- Collaborator: Linyi People's Hospital
- Collaborator class: OTHER
- Collaborator: Qianfoshan Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Linyi People's Hospital (`cardio:org-linyi-people-s-hospital`)
- Registry lists this organization as a collaborator: Qianfoshan Hospital (`cardio:org-qianfoshan-hospital`)

## Provenance

Content hash: dc181cda97eaab9b0614877570d938c5b738719f4d98cf37d535b14cb07b9df0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
